WELFUCO-150 contains Fluconazole 150 mg, a triazole antifungal formulated for the treatment of susceptible fungal infections, including appropriate candidal infections. A focused PCD Pharma Anti-Fungal portfolio product.
Susceptible fungal infections, including selected Candida infections.
No, it is an antifungal.
Use as prescribed and complete the recommended course. Inform the physician about liver disease, pregnancy, heart-rhythm problems and other medicines due to potential interactions.
Nausea, abdominal discomfort, diarrhea, headache, dizziness and skin rash may occur. Liver enzyme elevation can occur.
WELFUCO-150: Fluconazole inhibits fungal cytochrome P450-dependent 14-alpha-demethylase, reducing ergosterol synthesis and disrupting the fungal cell membrane.
